Literature DB >> 24463671

Association between stillbirth and illicit drug use and smoking during pregnancy.

Michael W Varner1, Robert M Silver, Carol J Rowland Hogue, Marian Willinger, Corette B Parker, Vanessa R Thorsten, Robert L Goldenberg, George R Saade, Donald J Dudley, Donald Coustan, Barbara Stoll, Radek Bukowski, Matthew A Koch, Deborah Conway, Halit Pinar, Uma M Reddy.   

Abstract

OBJECTIVE: To compare illicit drug and smoking use in pregnancies with and without stillbirth.
METHODS: The Stillbirth Collaborative Research Network conducted a case-control study from March 2006 to September 2008, covering more than 90% of deliveries to residents of five a priori-defined geographically diverse regions. The study attempted to include all stillbirths and representative liveborn controls. Umbilical cord samples from cases and controls were collected and frozen for subsequent batch analysis. Maternal serum was collected at delivery and batch analyzed for cotinine.
RESULTS: For 663 stillbirth deliveries, 418 (63%) had cord homogenate and 579 (87%) had maternal cotinine assays performed. For 1,932 live birth deliveries, 1,050 (54%) had cord homogenate toxicology and 1,545 (80%) had maternal cotinine assays performed. A positive cord homogenate test for any illicit drug was associated with stillbirth (odds ratio [OR] 1.94, 95% confidence interval [CI] 1.16-3.27). The most common individual drug was cannabis (OR 2.34 95% CI 1.13-4.81), although the effect was partially confounded by smoking. Both maternal self-reported smoking history and maternal serum cotinine levels were associated in a dose-response relationship with stillbirth. Positive serum cotinine less than 3 ng/mL and no reported history of smoking (proxy for passive smoke exposure) also were associated with stillbirth (OR 2.06, 95% CI 1.24-3.41).
CONCLUSION: Cannabis use, smoking, illicit drug use, and apparent exposure to second-hand smoke, separately or in combination, during pregnancy were associated with an increased risk of stillbirth. Because cannabis use may be increasing with increased legalization, the relevance of these findings may increase as well. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463671      PMCID: PMC3931517          DOI: 10.1097/AOG.0000000000000052

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  43 in total

1.  Association between marijuana use and adverse obstetrical and neonatal outcomes.

Authors:  C R Warshak; J Regan; B Moore; K Magner; S Kritzer; J Van Hook
Journal:  J Perinatol       Date:  2015-09-24       Impact factor: 2.521

2.  Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization.

Authors:  Torri D Metz; Robert M Silver; Gwendolyn A McMillin; Amanda A Allshouse; Triniti L Jensen; Chanel Mansfield; Kennon Heard; Gregory L Kinney; Erica Wymore; Ingrid A Binswanger
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

3.  Family Physicians' Perceived Prevalence, Safety, and Screening for Cigarettes, Marijuana, and Electronic-Nicotine Delivery Systems (ENDS) Use during Pregnancy.

Authors:  Thomas F Northrup; Michelle R Klawans; Yolanda R Villarreal; Adi Abramovici; Melissa A Suter; Joan M Mastrobattista; Carlos A Moreno; Kjersti M Aagaard; Angela L Stotts
Journal:  J Am Board Fam Med       Date:  2017 Nov-Dec       Impact factor: 2.657

4.  Physicians' Perceived Roles, as Well as Barriers, Toward Caring for Women Sex Assault Survivors.

Authors:  Priyanka Amin; Raquel Buranosky; Judy C Chang
Journal:  Womens Health Issues       Date:  2016-11-15

Review 5.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

6.  Public health messages about perinatal marijuana use in an evolving policy context.

Authors:  Marian Jarlenski; Jennifer Zank; Jill Tarr; Judy C Chang
Journal:  Subst Abus       Date:  2016-12-07       Impact factor: 3.716

Review 7.  Sex and gender differences in substance use disorders.

Authors:  R Kathryn McHugh; Victoria R Votaw; Dawn E Sugarman; Shelly F Greenfield
Journal:  Clin Psychol Rev       Date:  2017-11-10

8.  Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report use.

Authors:  Judy C Chang; Jill A Tarr; Cynthia L Holland; Natacha M De Genna; Gale A Richardson; Keri L Rodriguez; Jeanelle Sheeder; Kevin L Kraemer; Nancy L Day; Doris Rubio; Marian Jarlenski; Robert M Arnold
Journal:  Drug Alcohol Depend       Date:  2019-01-11       Impact factor: 4.492

9.  Pregnant Women's Access to Information About Perinatal Marijuana Use: A Qualitative Study.

Authors:  Marian Jarlenski; Jill A Tarr; Cynthia L Holland; David Farrell; Judy C Chang
Journal:  Womens Health Issues       Date:  2016-05-04

Review 10.  Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization.

Authors:  George Sam Wang
Journal:  J Med Toxicol       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.